The anticancer activity of resveratrol on implanted tumor of HepG2 in nude mice

田雪梅,张展霞
DOI: https://doi.org/10.3969/j.issn.1009-3079.2001.02.010
2001-01-01
World Chinese Journal of Digestology
Abstract:AIM: To study the anti-cancer effects of resveratrol in vivo. METHODS: Human hepatic cancer cells HepG2 were planted into nude mice to get the cancer model of HepG2. Resveratrol at different doses was injected into the carcinoma on the nude mice. After treatment, the carcinomas were cut and prepared with sections to observe the pathological change of the carcinoma tissue. Expression of PCNA and Bcl-2 in carcinoma tissues was detected by immunohistochemistry, and apoptosis of cells were labeled with TUNEL. RESULTS: Resveratrol can significantly inhibit carcinoma growth when it was injected into the carcinoma. The inhibition ratios were 38% and 36% at doses of 1 mg. kg-1 mass and 1.5 mg·kg-1 mass. Expression of PCNA (33% ± 6% and 84% ± 7%) and Bcl-2 (0.187 ± 0.007 and 0.835 ± 0.006) was lower than the control group. And resveratrol could cause hepatic cancer cell apoptosis. CONCLUSION: Resveratrol can inhibit progression of hepatic cancer, and this function may be attributed to the decreased expression of PCNA and Bcl-2 in the cancer cells, and induction of apoptosis may play a role in it.
What problem does this paper attempt to address?